🇺🇸 FDA
Pipeline program

SPD489

SPD489-403

Approved small_molecule completed

Quick answer

SPD489 for ADHD Specifically With Executive Function Impairment is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
ADHD Specifically With Executive Function Impairment
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials